According to the literature, GOLM1 can upregulate NEAT1 to promote pulmonary fibrosis, which is a major characteristic of BPD, before the implementation of antenatal steroids and surfactant therapy [12]. Here, GOLM1 is linked to bronchopulmonary dysplasia.